FDA
-
-
-
-
-
-
-
NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
-
-
-
-
-
-
-
Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant
-
-
-
-
322,967 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

